3 patients add $2.5B to Sarepta's value

3 patients add $2.5B to Sarepta's value

Source: 
Biopharma Dive
snippet: 

The market capitalization for Sarepta Therapeutics rocketed up billions of dollars after its gene therapy for a rare muscle disease showed early signs of safety, as well as an efficacy profile that some analysts described as beyond a home run.